Bioequivalence Study of Sulfadoxine/Pyrimethamine 500/25 mg Dispersible Tablet
Clinical trial NCT06522763 · UNKNOWN
Trial details
- NCT number
- NCT06522763
- Sponsor
- Swiss Pharma Nigeria Limited
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2024-08-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.